Clinical Trial Update: Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure [Phase 3]

View source ↗

Summary

Phase 3 trial of inhaled nitric oxide for hypoxic respiratory failure with pulmonary hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Respiratory Failure
• Pulmonary Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Hypoxic Respiratory Failure With Pulmonary Hypertension | Phase 3 | Status: WITHDRAWN